AzTrials
AzTrials

Lower Limb AmputationMOTU++ pedaneNCT06883942

Pilot Study on the Evaluation of the Functionality, Safety and Reliability of New Tripping Devices for Lower Limbs.

An observational study of Lower Limb Amputation and Slip Perturbations, run by Fondazione Don Carlo Gnocchi ETS at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study aims to identify prognostic biomarkers of fall risk in patients with lower limb amputation Read more about this study

Who is it for?
Ages 18 to 80 yearsHealthy volunteers can take part
What is being tested?
prosthetic group performs the entire protocol with their own prosthesis and Experimental Group
How many people
8 participants
Where
1 siteItaly
Study dates
6 Feb 2024to 17 Jul 2025
How long will I take part?
1 Week
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: subjects with monolateral trans-femoral and/or trans-tibial.

Who may be able to join

  • Trans-femoral or trans-tibial lower limb amputation;
  • Functional medical classification: Level K3-K4;
  • Subjects who have had a prosthesis for at least 1 year (experienced wearers);
  • Informed consent signed by the subject

Who cannot join

  • Significant medical comorbidities (severe neurological disease, cardiovascular disease diabetes/unstabilised hypertension, severe sensory deficits);
  • Cardiac device wearers (PMK or AICD);
  • Cognitive impairment (MMSE adjusted for age and schooling <24);
  • Inability or unwillingness to provide informed consent;
  • Severe depressive symptomatology - Beck Depression Inventory (BDI-II <19);
  • Severe anxiety symptoms - State-Trait Anxiety Inventory (STAI-Y <50).

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • IRCCS Fondazione Don Carlo Gnocchi

    Florence, Italy, 50143

Other trials in Italy

About this study

The study aims to identify prognostic biomarkers of fall risk in patients with lower limb amputation

Read the detailed description

The protocol will involve both trans-tibial and trans-femoral amputation subjects, for a total duration of up to 5 sessions.

Initially, the fall detection algorithm will be evaluated on trans-femoral and trans-tibial amputees performing the test while wearing their prosthesis.

In a second step, the experimentally obtained prognostic markers of fall risk will be studied (i.e., using one or both of the perturbation platforms described below).

The markers thus obtained are to be validated by comparison with markers already established in clinical practice or in the literature.

Experimental platforms The platforms are composed of a mechanism to simulate and investigate the aid that the prosthetic system can provide in the event of a source of tripping and/or slipping.

Being tested
prosthetic group performs the entire protocol with their own prosthesis, Experimental Group
Keywords
amputation, stumble, slipping, lower limb, fall risk

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • prosthetic group performs the entire protocol with their own prosthesisProcedure or surgery

    The 1st session is the enrolment and functional evaluation one. The following 2 we test the algorithm functionality verification; one session for both platforms. The last 2 sessions are necessary to acquire prognostic markers for falls; one session for both platforms.

    The balance disturbance tests will take place on two platforms:

    • The sliding platform consists of a metal supporting structure and a wooden cover, which has a manual release mechanism that allows the activation of the tile responsible for simulating the events that occur during sliding.
    • The stumbling platform consists of a metal supporting structure and a wooden cover, which features an electronically activated plastic and foam tripping mechanism that simulates the sequence of events that occur during a stumble.
  • Experimental GroupDevice

    The fall detection algorithm will be evaluated first. In a second step, the experimentally obtained prognostic markers of fall risk will be studied. The markers thus obtained shall be validated by comparison with markers already established in clinical practice or in the literature.

Study groups in NCT06883942
Study groupRoleWhat they receive
Subjects with unilateral trans-femoral and/or trans-tibial amputation.Not described
Receives: Procedure: prosthetic group performs the entire protocol with their own prosthesis; Device: Experimental Group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. algorithm validation

    Verifying the measurement performance of the trip and slip detection algorithm on prosthesis wearers

    Measured: baseline

Secondary outcomes (1)
  1. data aquiring

    Acquire data on amputees to be used for the development of a new version of the detection algorithm and its testing.

    Measured: baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Mar 2025
  2. Study start6 Feb 2024
  3. Primary completion17 Jul 2025
  4. Study completion17 Jul 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Other
Enrolment
8 participants (actual)
Target duration
1 Week
IDs, dates and publications
ClinicalTrials.gov ID
NCT06883942
Sponsor's protocol ID
MOTU++ Studio Clinico Pedane
Acronym
MOTU++ pedane
Status last verified
Mar 2025
First submitted
14 Feb 2025
Last updated
27 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Zhang F, D'Andrea SE, Nunnery MJ, Kay SM, Huang H. Towards design of a stumble detection system for artificial legs. IEEE Trans Neural Syst Rehabil Eng. 2011 Oct;19(5):567-77. doi: 10.1109/TNSRE.2011.2161888. Epub 2011 Aug 18.

    PubMed 21859635
  • Palumbo P, Randi P, Moscato S, Davalli A, Chiari L. Degree of Safety Against Falls Provided by 4 Different Prosthetic Knee Types in People With Transfemoral Amputation: A Retrospective Observational Study. Phys Ther. 2022 Apr 1;102(4):pzab310. doi: 10.1093/ptj/pzab310.

    PubMed 35079822
  • Hunter SW, Batchelor F, Hill KD, Hill AM, Mackintosh S, Payne M. Risk Factors for Falls in People With a Lower Limb Amputation: A Systematic Review. PM R. 2017 Feb;9(2):170-180.e1. doi: 10.1016/j.pmrj.2016.07.531. Epub 2016 Jul 30.

    PubMed 27485674
  • Miller WC, Speechley M, Deathe B. The prevalence and risk factors of falling and fear of falling among lower extremity amputees. Arch Phys Med Rehabil. 2001 Aug;82(8):1031-7. doi: 10.1053/apmr.2001.24295.

    PubMed 11494181

Questions about this trial

What is this clinical trial studying?

An observational study of Lower Limb Amputation and Slip Perturbations, run by Fondazione Don Carlo Gnocchi ETS at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

algorithm validation (time frame: baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06883942, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Mar 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in